Increased CA 19-9 level in patients without malignant disease

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 6, 2009, Pages 750-754

  Kim, Hye Ryoun ^a   Lee, Chang Hyun ^b   Kim, Young Whan ^a   Han, Sung Koo ^a   Shim, Young Soo ^a   Yim, Jae Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bronchiectasis; Bronchiolitis; Carbohydrate antigen 19 9 (CA 19 9) antigen; Emphysema; Pulmonary fibrosis

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BRONCHIECTASIS; BRONCHIOLITIS; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMPHYSEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; PANCREAS CANCER; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEOPLASMS; RESPIRATORY FUNCTION TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 67650613956     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.152     Document Type: Article

References (28)

1. Tempero MA, Uchida E, Takasaki H, Burnett DA, Steplewski Z, Pour PM. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res 1987;47:5501-3.
2. Koprowski H, Herlyn M, Steplewski Z, Sears HF. Specific antigen in serum of patients with colon carcinoma. Science 1981;212:53-5.
3. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 1979;5: 957-71.
4. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007;33:266-70.
5. Boeck S, Stieber P, Holdenrieder S, Wilkowski R, Heinemann V. Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer. Oncology 2006;70:255-64.
6. Duffy MJ, O'Sullivan F, McDonnell TJ, FitzGerald MX. Increased concentrations of the antigen CA-19-9 in serum of cystic fibrosis patients. Clin Chem 1985;31: 1245-6.
7. Yokoyama A, Kohno N, Kondo K, Ueda S, Hirasawa Y, Watanabe K, et al. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia. Respirology 1998; 3:199-202.
8. Uyama T, Monden Y, Harada K, Tsuzuki H, Hashioka K, Nobuhara K, et al. A case of intralobar pulmonary sequestration with calcification and elevated serum values of carcinoembryonic antigen and carbohydrate antigen 19-9. J Thorac Imaging 1989;4:74-6.
9. Watanabe K, Fujimura M, Kasahara K, Yasui M, Myou S, Watanabe A, et al. Characteristics of pulmonary Myco-bacterium avium-intracellulare complex (MAC) infection in comparison with those of tuberculosis. Respir Med 2003;97:654-9.
10. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 1983;29:549-52.
11. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
12. Gotway MB, Freemer MM, King TE Jr. Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idio-pathic interstitial pneumonias. Thorax 2007;62:546-53.
13. Barker AF. Bronchiectasis. N Engl J Med 2002;346: 1383-93.
14. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, et al. Pulmonary tuberculosis: CT findings - early active disease and sequential change with antituberculous therapy. Radiology 1993;186:653-60.
15. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-27.
16. Parra JL, Kaplan S, Barkin JS. Elevated CA 19-9 caused by Hashimoto's thyroiditis: review of the benign causes of increased CA 19-9 level. Dig Dis Sci 2005;50:694-5.
17. Akdogan M, Sasmaz N, Kayhan B, Biyikoglu I, Disibeyaz S, Sahin B. Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature. Tumori 2001;87:337-9.
18. Giannaris M, Dourakis SP, Alexopoulou A, Archimandri-tis AJ. Markedly elevated CA 19-9 in the pus and the serum of a patient with pyogenic liver abscess. J Clin Gastroenterol 2006;40:657.
19. Nakamura T, Maruyama K, Kashiwabara H, Sunayama K, Ohata K, Fukazawa A, et al. Diverticulitis causing a high serum level of carbohydrate antigen 19-9: report of a case. Surg Today 2002;32:282-4.
20. Nakajima T, Terashima T, Nishida J, Onoda M, Koide O. Treatment of bronchorrhea by corticosteroids in a case of bronchioloalveolar carcinoma producing CA19-9. Intern Med 2002;41:225-8.
21. Mozas J, Castilla JA, Jimena P, Gil T, Acebal M, Herruzo AJ. Serum CA-125 in the diagnosis of acute pelvic inflammatory disease. Int J Gynaecol Obstet 1994;44: 53-7.
22. Shimomura C, Eguchi K, Kawakami A, Migita K, Nakao H, Otsubo T, et al. Elevation of a tumor associated antigen CA 19-9 levels in patients with rheumatic diseases. J Rheumatol 1989;16:1410-5.
23. Szekanecz E, Sandor Z, Antal-Szalmas P, Soos L, Lakos G, Besenyei T, et al. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation? Ann NY Acad Sci 2007;1108: 359-71.
24. Uygur-Bayramicli O, Dabak R, Orbay E, Dolapcioglu C, Sargin M, Kilicoglu G, et al. Type 2 diabetes mellitus and CA 19-9 levels. World J Gastroenterol 2007;13:5357-9.
25. Benhamou PY, Vuillez JP, Halimi S, Meffre G, Bachelot I. Influence of metabolic disturbances of diabetes melli-tus on serum CA 19-9 tumor marker. Diabetes Metab 1991;17:39-43.
26. Aoki Y, Yanagisawa Y, Ohfusa H, Kawa S, Oguchi H, Furuta S. Elevation of serum CA 19-9 in parallel with HbA1c in a diabetic female with the Lewis(aqb-) blood group. Diabetes Res Clin Pract 1991;13:77-81.
27. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 2008;31 Suppl 2:S161-4.
28. Mita T, Watada H, Uchino H, Shimizu T, Hirose T, Tanaka Y, et al. Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus. Endocr J 2006;53: 693-8.